header("Access-Control-Allow-Origin: *"); ?>
Initial Accreditation Date:Jul 07 , 2011
Umm Suqeim Road | Al Barsha South | Dubai Biotechnology & Research Park (DuBiotech) | Ground Floor | Lab no. 0013 Dubai | United Arab Emirates, Dubai, United Arab Emirates
92323
fibrahim@nrl.ae snarang@nrl.ae
www.nrl.ae
+971 04 444 4444
| Type of Biological Sample | Components / Analytes | Examination Technique | Examination Procedure | Status | |
|---|---|---|---|---|---|
| Serology | |||||
|
|
| NRL-CM-SOP-008 | Active | |
|
| NRL-IMM-SOP-010 | Active | ||
|
| NRL-IMM-SOP-064 | Active | ||
|
| NRL-IMM-SOP-063 | Active | ||
| NRL-IMM-SOP-017 | Active | |||
| NRL-IMM-SOP-016 | Active | |||
|
|
| NRL-MHD-POCT-SOP-005 | Active | |
|
| NRL-MHD-POCT-SOP-006 | Active | ||
|
| NRL-MHD-POCT-SOP-007 | Active | ||
| Hematology | |||||
|
|
| NRL-HEME-SOP-040 | Active | |
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
|
| NRL-HEME-SOP-040 | Active | ||
|
| NRL-HEME-SOP-040 | Active | ||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
|
| NRL-HEME-SOP-040 | Active | ||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| NRL-HEME-SOP-040 | Active | |||
| Biochemistry | |||||
|
|
| NRL-MHD-AC-001 | Active | |
|
| NRL-MHD-AC-002 | Active | ||
|
| NRL-MHD-AC-003 | Active | ||
|
| NRL-MHD-AC-004 | Active | ||
|
| NRL-MHD-AC-005 | Active | ||
|
| NRL-MHD-AC-006 | Active | ||
| NRL-MHD-AC-007 | Active | |||
|
| NRL-MHD-AC-008 | Active | ||
|
| NRL-MHD-AC-009 | Active | ||
|
| NRL-MHD-AC-010 | Active | ||
|
| NRL-MHD-AC-011 | Active | ||
|
| NRL-MHD-AC-012 | Active | ||
|
| NRL-MHD-AC-013 | Active | ||
|
| NRL-MHD-AC-014 | Active | ||
|
| NRL-MHD-AC-015 | Active | ||
|
| NRL-MHD-AC-017 | Active | ||
|
| NRL-MHD-AC-018 | Active | ||
|
| NRL-MHD-AC-019 | Active | ||
|
| NRL-MHD-AC-020 | Active | ||
|
| NRL-MHD-AC-021 | Active | ||
|
| NRL-MHD-AC-022 | Active | ||
|
| NRL-MHD-AC-024 | Active | ||
|
| NRL-MHD-AC-025 | Active | ||
|
| NRL-MHD-AC-026 | Active | ||
|
| NRL-MHD-AC-027 | Active | ||
|
| NRL-MHD-AC-028 | Active | ||
|
|
| NRL-MHD-AC-043 | Active | |
|
|
| NRL-MHD-AC-023 | Active | |
| NRL-MHD-AC-023 | Active | |||
| NRL-MHD-AC-023 | Active | |||
|
| NRL-MHD-AC-029 | Active | ||
| NRL-MHD-AC-030 | Active | |||
| NRL-MHD-AC-031 | Active | |||
| NRL-MHD-AC-032 | Active | |||
| NRL-MHD-AC-033 | Active | |||
| NRL-MHD-AC-034 | Active | |||
| NRL-MHD-AC-035 | Active | |||
| NRL-MHD-AC-036 | Active | |||
| NRL-MHD-AC-037 | Active | |||
| NRL-MHD-AC-038 | Active | |||
| NRL-MHD-AC-039 | Active | |||
| NRL-MHD-AC-040 | Active | |||
| NRL-MHD-AC-041 | Active | |||
| NRL-MHD-AC-042 | Active | |||
|
|
| NRL-MHD-AC-012 | Active | |
|
|
| NRL-MHD-AC-016 | Active | |
| Clinical Pathology | |||||
|
|
| NRL-MHD-POCT-SOP-004 | Active | |
|
| NRL-CM-SOP-002 | Active | ||
| NRL-CM-SOP-002 | Active | |||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
| NRL-CM-SOP-002 | Active | |||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
|
| NRL-CM-SOP-002 | Active | ||
| NRL-CM-SOP-002 | Active | |||